BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23113592)

  • 1. Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy.
    Alevronta E; Lind H; Al-Abany M; Waldenström AC; Olsson C; Dunberger G; Mavroidis P; Nyberg T; Johansson KA; Åvall-Lundqvist E; Steineck G; Lind BK
    Acta Oncol; 2013 May; 52(4):719-26. PubMed ID: 23113592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defecation into clothing without forewarning and mean radiation dose to bowel and anal-sphincter among gynecological cancer survivors.
    Lind H; Alevronta E; Steineck G; Waldenström AC; Nyberg T; Olsson C; Wilderäng U; Dunberger G; Al-Abany M; Åvall-Lundqvist E
    Acta Oncol; 2016 Nov; 55(11):1285-1293. PubMed ID: 27173757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationships of the sigmoid for urgency syndrome after gynecological radiotherapy.
    Alevronta E; Skokic V; Wilderäng U; Dunberger G; Sjöberg F; Bull C; Bergmark K; Jörnsten R; Steineck G
    Acta Oncol; 2018 Oct; 57(10):1352-1358. PubMed ID: 29733238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivors.
    Alsadius D; Hedelin M; Lundstedt D; Pettersson N; Wilderäng U; Steineck G
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e181-5. PubMed ID: 22677373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum.
    al-Abany M; Helgason AR; Cronqvist AK; Lind B; Mavroidis P; Wersäll P; Lind H; Qvanta E; Steineck G
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1035-44. PubMed ID: 15752882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
    Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Radiobiological study of 65 consecutive patients.
    Mavroidis P; al-Abany M; Helgason AR; Agren Cronqvist AK; Wersäll P; Lind H; Qvanta E; Theodorou K; Kappas C; Lind BK; Steineck G; Brahme A
    Strahlenther Onkol; 2005 May; 181(5):293-306. PubMed ID: 15900425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy.
    Fokdal L; Honoré H; Høyer M; von der Maase H
    Radiother Oncol; 2005 Feb; 74(2):203-10. PubMed ID: 15734208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent dose-response relation for absence of vaginal elasticity after gynecological radiation therapy.
    Alevronta E; Åvall-Lundqvist E; Al-Abany M; Nyberg T; Lind H; Waldenström AC; Olsson C; Dunberger G; Bergmark K; Steineck G; Lind BK
    Radiother Oncol; 2016 Sep; 120(3):537-541. PubMed ID: 26907514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls.
    Dunberger G; Lind H; Steineck G; Waldenström AC; Nyberg T; Al-Abany M; Nyberg U; Vall-Lundqvist E
    Eur J Cancer; 2010 Feb; 46(3):606-15. PubMed ID: 19926277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships of intestinal organs and excessive mucus discharge after gynaecological radiotherapy.
    Alevronta E; Skokic V; Dunberger G; Bull C; Bergmark K; Jörnsten R; Steineck G
    PLoS One; 2021; 16(4):e0250004. PubMed ID: 33861779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer.
    Thor M; Olsson CE; Oh JH; Petersen SE; Alsadius D; Bentzen L; Pettersson N; Muren LP; Waldenström AC; Høyer M; Steineck G; Deasy JO
    Acta Oncol; 2015; 54(9):1326-34. PubMed ID: 26340136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy.
    Smeenk RJ; Hoffmann AL; Hopman WP; van Lin EN; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):636-44. PubMed ID: 22137024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal incontinence affecting quality of life and social functioning among long-term gynecological cancer survivors.
    Dunberger G; Lind H; Steineck G; Waldenström AC; Nyberg T; al-Abany M; Nyberg U; Avall-Lundqvist E
    Int J Gynecol Cancer; 2010 Apr; 20(3):449-60. PubMed ID: 20375813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
    Vinod SK; Caldwell K; Lau A; Fowler AR
    J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?
    Cella L; Palma G; Deasy JO; Oh JH; Liuzzi R; D'Avino V; Conson M; Pugliese N; Picardi M; Salvatore M; Pacelli R
    PLoS One; 2014; 9(10):e111753. PubMed ID: 25360627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.